Stanford Neurogenetics and Neurogenomics Team

Search by Category

Search by Division

Steven Chang, MD
Professor of Neurosurgery
Director, Neurogentic Oncology Program

Dr. Steven Chang received his medical degree from Stanford University. He completed his neurosurgical training at Stanford with a focus on stereotactic radiosurgery, cerebrovascular disease, and brain and spinal tumors. He is recognized as an expert in Cyberknife radiosurgery and surgical resection of brain tumors. Dr. Chang is a research interest in neurogenetics and proteomics.


Kevin Graber, MD
Clinical Professor of Neurology & Neurological Sciences
Director of Outpatient Epilepsy Clinic

Dr. Kevin Graber earned his MD from Indiana University in 1992 and completed his training in Neurology & Neurological Sciences at Stanford Medical Center. Dr Graber has earned prestigious research awards and has served on several national committees including the American Epilepsy Society, CURE, and Epilepsy Foundation. As a Clinician Educator, Dr. Graber provides clinical care to patients with epilepsy, and teaches fellows, residents, and medical students. Dr. Graber's research is focused on discovering how brain injuries, such as trauma, lead to epilepsy.


Maxwell Greene, MD
Clinical Assistant Professor of Neurology & Neurological Sciences

Dr. Greene received his medical degree from Thomas Jefferson University in Philadelphia, where he was inducted into the Gold Humanism Honor Society, and was the recipient of the American Academy of Neurology medical student prize for excellence in Neurology. He then went on to complete neurology residency at the University of Pennsylvania, where he was the recipient of an R25 grant from the NIH, and won the Samuel T. Zeritsky award for research at Penn. He then completed fellowship in EMG and Neuromuscular Medicine and a research fellowship at the University of Pennsylvania.

Dr. Greene is board-certified in Neurology and Neuromuscular Medicine by the American Board of Psychiatry and Neurology. He was an Assistant Professor at the University of California, San Francisco, from 2017 before joining Stanford in 2020.  His interests and research include acquired and inherited neuromuscular diseases, including nerve disorders such as Charcot Marie Tooth (CMT) and Amyotrophic Lateral Sclerosis (ALS), and muscle disorders such as Myotonic Dystrophy and Facioscapulohumeral Muscular Dystrophy (FSH, FSHD).  


Jaimie M. Henderson, MD
John and Jene Blume - Robert and Ruth Halperin Professor
Director, Stereotactic and Functional Neurosurgery

Dr. Henderson has directed the Stereotactic and Functional Neurosurgery program at Stanford since 2004. He is an internationally recognized expert in neuromodulation (the use of implantable devices such as deep brain stimulators and other neurostimulation devices) to treat neurological disorders. He was an investigator in the first multi-center trial of deep brain stimulation (DBS) in the United States from 1996-1999, and has continued to pioneer this therapy over the past two decades, participating in studies of DBS for a number of disorders including  epilepsy and depression. From 2007-2009, Dr. Henderson was elected to serve as President of the North American Neuromodulation Society, guiding policy and promoting awareness of this new and rapidly growing field.

Throughout his career, Dr. Henderson has been intimately involved in the development of the field of image-guided surgery, which has revolutionized the practice of neurosurgery, allowing for safer and more effective operations with reduced operating time. His groundbreaking work on  frameless functional neurosurgery has become the standard technique for many neurosurgeons throughout the world. His areas of clinical interest include the treatment of movement disorders, epilepsy and pain, leveraging the innovations he has helped develop in image-guided surgery and neuromodulation

Dr. Henderson's current research focuses on the development of new neural interfacing techniques and the fundamental understanding of their mechanisms of action. He co-directs the Stanford Neural Prosthetics Translational Laboratory with Krishna Shenoy, Ph.D., (Departments of Neuroscience and Electrical Engineering), developing brain-computer interface systems and the investigating how the human brain controls movement. He is currently directing a clinical trial investigating the use of DBS to improve attention and concentration for people who have suffered moderate-to-severe traumatic brain injury.


Scheherazade Le, MD
Clinical Professor of Neurology & Neurological Sciences

Dr. Le's clinical research is focused on waveform analysis of motor evoked potentials and the prevention of spinal motor deficits in the intraoperative setting. She is also interested in developing techniques to obtain motor evoked potentials under partial paralysis in the endovascular suite. She is involved with trainee education and has clinical interests in epilepsy, electroencephalography and general neurology.


Yi Li, MD, PhD
Clinical Assistant Professor of Neurology & Neurological Sciences

Dr. Yi Li received her M.D. and Ph.D. in neurology and neuroscience from Central South University in China. She completed her residency training from University of Massachusetts Medical School, during which time she received a Safety and Quality Award from the American Academy of Neurology. She then continued her training as an epilepsy clinical and research fellow at Stanford. She is also a graduate of the Stanford Genetics and Genomics Certificate Program which develops skills in the field of genetics, genomics, and personalized medicine. She joined the faculty at Stanford in 2020, and has been interested in finding biomarkers to help epilepsy patients to identify disease risks as well as personalized treatment. Her area of interest includes medically refractory epilepsy management, precision medicine and genetics in epilepsy, epilepsy clinical research, and improving quality of patient care.  


Lawrence Recht, MD
Professor of Neurology and Neurological Sciences
Director, Adult Neuro-Oncology

Dr. Lawrence Recht received his medical degree from Columbia University College of Physicians and Surgeons in New York City. He completed his training as a Resident in Neurology at Columbia Presbyterian, Neurological Institute of New York. His interest in helping people with brain tumors led him to additional training and completion of a Fellowship in Neuro-Oncology at Memorial Sloan Kettering Cancer Institute in New York.

As an attending in Neurology with a specialty in Neuro-Oncology, Dr. Recht moved to the University of Massachusetts Medical School where he spent 19 years caring for patients and working in his research lab to try to find a cure for brain tumor. During this time Dr. Recht became convinced that it was better for patients to find out how and why a brain tumor evolved so that it could be treated earlier rather than directing his efforts toward treating the tumor after it had already caused disability.

In 2004, Dr Recht relocated to Stanford to work on furthering his research on Early Detection of Brain Tumor and to develop an expanded Adult Neuro-Oncology Program. Belief in hope and quality of life drives Dr. Recht and his team's practice of caring for patients and families with brain tumor and neurologic complications of cancer. Clinical studies are also provided and available for patients with specific conditions who are interested in adding experimental treatments to their care.

Efforts in Dr. Recht's research laboratory are directed towards applying early detection strategies to the treatment of brain tumors. In addition, other work in his laboratory is directed at reversing the damaging side effects of treatment-related brain injury.


Sarada Sakamuri, MD
Clinical Associate Professor of Neurology and Neurological Sciences

Dr. Sakamuri received her medical degree from New Jersey Medical School in Newark, NJ, where she focused on community health education and was elected a member of the Alpha Omega Alpha Honor Society.  She completed her neurology residency at Stanford University and served as chief resident.  She pursued her passion for neuromuscular disorders by completing fellowships in EMG/Clinical Neurophysiology and Neuromuscular Medicine at Stanford, and a concurrent research fellowship at Forbes Norris MDA/ALS Research Center.

Dr. Sakamuri is board-certified in Neurology and in Neuromuscular disorders by the American Board of Psychiatry and Neurology.  Her interests and research include respiratory dysfunction in neuromuscular disease, Lambert Eaton myasthenic syndrome, nemaline myopathies, and myotonic dystrophy.  

Dr. Sakamuri also enjoys medical education.  She is the Associate Director of the Neuromuscular Medicine Fellowship.  She previously served as a teaching fellow for medical students at Stanford School of Medicine, and as a clinical instructor at Jagiellonian University Medical College in Poland.


Jacinda Sampson, MD, PhD
Clinical Professor of Neurology and Neurological Sciences

Dr. Jacinda Sampson received her MD and a PhD in biochemistry from University of Alabama at Birmingham, and completed her neurology residency and neurogenetics fellowship at the University of Utah. She served at Columbia University Medical Center prior to joining Stanford University Medical Center in 2015. Her areas of interest include myotonic dystrophies, Duchenne muscular dystrophy, and neurogenetic disorders such as neurofibromatosis, hereditary spastic paraparesis, spinocerebellar ataxia, among others. She is interested in clinical trials for treatment of neurogenetic disorders, and in the clinical application of next-generation genomic sequencing to genetic testing.


Neil Schwartz, MD, PhD
Clinical Professor of Neurology and Neurological Sciences

Dr. Schwartz joined the Stanford Stroke Center in 2004 as a Fellow in Vascular Neurology and has remained on as Faculty since 2007. Currently, his primary focus is the care of patients with cerebrovascular disease in both the inpatient and outpatient setting. He has expertise in caring for patient with both ischemic and hemorrhagic strokes. He has a particular interest and expertise in cervical artery dissection and non-atherosclerotic vasculopathies, and serves as the Director of the new Young Stroke Program at Stanford. Dr Schwartz is a national leader in neurological education and is the Program Director for the Stanford Neurology Residency Program and is the Medical Director of inpatient Neurology and Neurosurgery wards for Stanford Health Care.


Sharon Sha, MD, MS
Clinical Professor, Neurology & Neurological Sciences

Dr. Sha received her Bachelor’s degrees in Cognitive Science and Molecular Cell Biology emphasizing in Neurobiology from UC Berkeley. She went on to obtain a Master’s degree in Physiology and MD from Georgetown University. She trained in Neurology at UCLA and Stanford University and completed a clinical and research fellowship in behavioral neurology at UCSF where she focused on identifying biomarkers for genetic forms of frontotemporal dementia and caring for patients with movement disorders and cognitive impairment.

Dr. Sha’s clinical expertise include Alzheimer’s disease, frontotemporal dementia, Lewy Body disease, corticobasal syndrome, progressive supranuclear palsy, Huntington’s disease, ataxia, multiple system atrophy, and other dementias. She is currently director of the Huntington’s disease and Ataxia clinic.

Dr. Sha’s non-clinical time is spent conducting clinical trials as the Director of the Memory Disorders Clinical Trials Program in order to identify disease modifying treatments for dementia. She has a special interest in genetic forms of dementia and the cognitive impairment in parkinsonian-related disorders. She is also director of the Stanford Behavioral Neurology Clinical Fellowship.


Carly Siskind, MS, LCGC
Senior Genetic Counselor, Assistant Clinical Professor – Affiliated

Before joining the neuromuscular team in 2011, Carly Siskind worked in neurogenetics at Wayne State University in Detroit. She sees patients both at Stanford Hospital and Clinics and Lucile Packard Children’s Hospital. Ms. Siskind is a Clinical Assistant Professor of Neurology (Affiliated), with her main research focus being Charcot-Marie-Tooth disease.

Ms. Siskind obtained her Bachelor’s degree from the University of Michigan with a major in Biology, minor in Global Change and a teaching certificate for high school science. She obtained her Master’s degree from Northwestern University in Chicago. She was board certified by the National Society of Genetic Counselors in 2009 and licensed by the state of California in 2011.


Thomas J. Wilson, MD
Clinical Associate Professor, Neurosurgery

Dr. Thomas J. Wilson was born in Omaha, Nebraska.  He attended the University of Nebraska College of Medicine, earning his MD with highest distinction.  While a medical student, he was awarded a Howard Hughes Medical Institute Research Training Fellowship and spent a year in the lab of Dr. Rakesh Singh at the University of Nebraska.  He completed his residency training in neurological surgery at the University of Michigan and was mentored by Dr. Lynda Yang and Dr. John McGillicuddy in peripheral nerve surgery.  Following his residency, he completed a fellowship in peripheral nerve surgery at the Mayo Clinic in Rochester, Minnesota, working with Dr. Robert Spinner.  He is now Clinical Assistant Professor and Co-Director of the Center for Peripheral Nerve Surgery at Stanford University.  He is also currently endeavoring to earn a Master of Public Health (MPH) degree from the prestigious Bloomberg School of Public Health at Johns Hopkins University. His research interests include peripheral nerve outcomes research using large data sets and multi-institutional registries, clinical trials advancing options for patients with peripheral nerve pathologies, and translational research focused on deriving methods for data-driven intraoperative decision making using intraoperative electrophysiology, advanced imaging techniques, and genetic expression information.  His wife, Dr. Monique Wilson, is a practicing dermatologist in the Bay Area.